Načítá se...
Clobetasol promotes remyelination in a mouse model of neuromyelitis optica
Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of the central nervous system that can produce marked neurological deficit. Current NMO therapies include immunosuppressants, plasma exchange and B-cell depletion. Here, we evaluated 14 potential remyelinating drugs emerging from pr...
Uloženo v:
| Vydáno v: | Acta Neuropathol Commun |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4845317/ https://ncbi.nlm.nih.gov/pubmed/27117475 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40478-016-0309-4 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|